Navigation Links
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Date:5/18/2009

RISPERDAL(R) CONSTA(R) is the First and Only Long-Acting Antipsychotic Therapy Available for Bipolar I Disorder

TITUSVILLE, N.J., May 18 /PRNewswire/ -- Janssen(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

Bipolar Disorder is a brain disorder that causes unusual shifts in a person's mood, energy and ability to function. It is often characterized by debilitating mood swings from extreme highs (mania) to extreme lows (depression). Type I Bipolar Disorder is characterized based on the occurrence of at least one manic episode, with or without the occurrence of a major depressive episode, and affects approximately 1 percent of the American adult population in any given year.

"Long-acting therapies are moving to the forefront of treatment for mental illness, and the approval of risperidone long-acting treatment for Bipolar Disorder is exciting because it offers physicians assurance that the medication is being taken as prescribed," said Caleb Adler, M.D., principal investigator and associate professor of Clinical Psychiatry at the University of Cincinnati. "Further the bi-weekly administration schedule encourages regular contact between patients and their treatment team."

The approval is based on two prospective, randomized, double-blind, placebo-controlled studies for the long-term treatment of Bipolar I Disorder. The first demonstrated that RISPERDAL(R) CONSTA(R), when used as a monotherapy, was significantly better than placebo at delaying the time to relapse of any mood episode. The second study demonstrated that, for patients already taking lithium or valpro
'/>"/>

SOURCE Janssen Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
2. "Farrah's Law" Grants Fawcett's Last Request
3. UnitedHealthcare Childrens Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey
4. UnitedHealthcare Childrens Foundation To Award More Medical Grants for Child Health Care Needs in Connecticut
5. FDA Grants Priority Review Status to Prevnar 13 Marketing Application
6. Regence Foundation Grants $390,000 to Improve Health Care Safety Net
7. Medical University of South Carolina Automates Grants Allocation Process with Lombardi Business Process Management Software
8. American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program
9. Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants
10. Parent Project Muscular Dystrophy Awards Two End Duchenne Grants
11. Video: CVS Caremark Charitable Trust Awards $4.2 Million in Grants Benefiting Children with Disabilities, Uninsured
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend ... disorders, are now offering a wide variety of treatments ... characterized by the presence of phantom sounds or ringing ... is a prevalent symptom that can arise due to ... tinnitus can impede a person’s quality of life. , ...
(Date:3/28/2015)... Aliso Viejo, California (PRWEB) March 28, 2015 ... have announced a new overlay entitled Scratches 5K from ... overlay grungy scratch effects to any media inside Final ... Film Studios. “StoryBoard Corporate saves time and is an ... any media using FCPX Overlay Scratches 5K's intuitive grunge ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 ... of dietary supplements announces the release of their ... was shown in two randomized, double-blind, placebo-controlled clinical ... and waist and hip size. MuffinStop™ is a ... indicus and Garcinia mangostana, fused together to create ...
(Date:3/28/2015)... LTW Cyber is an innovation hub ... the purpose of addressing the needs of the global ... own opportunities to grow while seeking collaborative opportunities with ... , Ventures in LTW Cyber focus on secure application ... identifying vulnerabilities and analyzing open source. As the ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Wellness for ... and business criteria for the spa and wellness industry–has ... clients who have experienced or are living with cancer. ... Spafinder Wellness 365® Network, will be identified with a ... as a provider of safe, therapeutic services for cancer ...
Breaking Medicine News(10 mins):Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... of over $50 to,Doctors, ALBANY, N.Y., May ... Committee reported key legislation (see vote count,below) to ... in New York,State. Governor Paterson,s bill, A.11187, sponsored ... gifts of over $50 to doctors and,requires doctors ...
... Corporation, the,leader in dry-state, room temperature biosample management ... part of GE Healthcare, will,become a non-exclusive distributor ... The GenSolve DNA recovery kit enables FTA(R)1 ... archived samples with a simple, user-friendly,and reliable procedure. ...
... 29 Three of the most terrifying words in,the English ... word,"prostate" and the fear factor rises even higher, since prostate ... but with early,detection is very curable., Give a gift ... a simple,blood test to screen for prostate cancer. If there ...
... sex, age and ethnicity has a significant impact on ... study led by researchers at the University of Southern ... , While age and ethnicity are well-established factors ... that gender also plays an important role in overall ...
... read and have good phonetic skills - the ability to ... poor spellers. In a paper published in the May 2008 ... School of Psychology of Leicester, UK, show that this subgroup ... other poor spellers. , The three-year study was carried out ...
... Calif., May 29 Alsius Corporation,(Nasdaq: ... temperature,management (IVTM(TM)) therapies for critically ill patients, ... Partners, L.P. to provide,intravascular temperature management products ... is the fifth contract we have been ...
Cached Medicine News:Health News:Assembly on the Move for Rx Reform 2Health News:Assembly on the Move for Rx Reform 3Health News:Whatman, Now Part of GE Healthcare, to Distribute GenVault DNA Recovery Kits in North America 2Health News:Whatman, Now Part of GE Healthcare, to Distribute GenVault DNA Recovery Kits in North America 3Health News:Give the Man in Your Life the Gift of Health 2Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Alsius Corporation Awarded Three-Year Agreement With Premier, Inc. 2Health News:Alsius Corporation Awarded Three-Year Agreement With Premier, Inc. 3
(Date:3/27/2015)... The Temple Health & Bioscience District (THBD) today announced it ... South First St. in the Temple Medical and Education District ... of Temple to receive funding for redevelopment. Located ... Health Care System, the new facility will enable THBD to ... life science companies. Temple ...
(Date:3/27/2015)... 27, 2015 XRpro Sciences, Inc., a ... and development services which features high throughput transporter ... announced financial results for the year ended December ... Chairman of XRpro Sciences commented, "We have completed ... development stage to commercial stage in large part ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
Breaking Medicine Technology:Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today reported financial ... For the first quarter of 2011, Rigel reported a net loss ... loss of $22.3 million, or $0.43 per share, in the first ... of 2011 and 2010 were 52.3 million and 52.0 million, respectively. ...
... 3, 2011 Delcath Systems, Inc. (Nasdaq: DCTH ... the newly created position of Executive Vice President, Global Operations. ... and operations team, and will implement logistics and supply chain ... later this year. Mr. Mapes will report directly to Eamonn ...
Cached Medicine Technology:Rigel Announces First Quarter Financial Results 2Rigel Announces First Quarter Financial Results 3Rigel Announces First Quarter Financial Results 4Delcath Names Harold C. Mapes as Executive Vice President of Global Operations 2Delcath Names Harold C. Mapes as Executive Vice President of Global Operations 3
... including aspiration holes and additional electrode ... requiring precise dissection with decreased risk ... demands. ,Flexible design options allow ... electrodes and multiple tip designs. Optimize ...
... Enhanced features including aspiration holes and ... laparoscopic procedures requiring precise dissection with ... increased suction demands. ,Flexible design ... and nonretractable electrodes and multiple tip ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: